Cardinal Health Cost of product sold — Total Costs & Expenses decreased by 3.1% to $3.12B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.1%, from $3.12B to $3.12B. Over 2 years (FY 2023 to FY 2025), Cost of product sold — Total Costs & Expenses shows relatively stable performance with a 0.5% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Monitoring this helps assess the total cost structure and its impact on segment profitability.
This metric aggregates all costs and expenses associated with the cost of product sold segment, including direct product...
Standard total operating cost metric for business segments.
cah_segment_cost_of_product_sold_costs_and_expenses| Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.09B | $3.09B | $3.09B | $3.09B | $3.07B | $3.07B | $3.07B | $3.07B | $3.12B | $3.14B | $3.12B | $3.13B | $3.14B | $3.22B | $3.12B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -0.6% | +0.0% | +0.0% | +0.0% | +1.4% | +0.7% | -0.5% | +0.3% | +0.3% | +2.7% | -3.1% |
| YoY Change | — | — | — | — | -0.6% | -0.6% | -0.6% | -0.6% | +1.4% | +2.1% | +1.6% | +1.8% | +0.7% | +2.7% | +0.1% |